These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26951658)

  • 1. PP2A methylation controls sensitivity and resistance to β-amyloid-induced cognitive and electrophysiological impairments.
    Nicholls RE; Sontag JM; Zhang H; Staniszewski A; Yan S; Kim CY; Yim M; Woodruff CM; Arning E; Wasek B; Yin D; Bottiglieri T; Sontag E; Kandel ER; Arancio O
    Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3347-52. PubMed ID: 26951658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Expression of the PP2A Methylesterase, PME-1, or the PP2A Methyltransferase, LCMT-1, Alters Sensitivity to Beta-Amyloid-Induced Cognitive and Electrophysiological Impairments in Mice.
    Staniszewski A; Zhang H; Asam K; Pitstick R; Kavanaugh MP; Arancio O; Nicholls RE
    J Neurosci; 2020 Jun; 40(23):4596-4608. PubMed ID: 32341098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice.
    Gnanaprakash M; Staniszewski A; Zhang H; Pitstick R; Kavanaugh MP; Arancio O; Nicholls RE
    J Alzheimers Dis; 2021; 79(4):1813-1829. PubMed ID: 33459709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid.
    Asam K; Staniszewski A; Zhang H; Melideo SL; Mazzeo A; Voronkov M; Huber KL; Pérez E; Stock M; Stock JB; Arancio O; Nicholls RE
    PLoS One; 2017; 12(12):e0189413. PubMed ID: 29253878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation.
    Sontag E; Nunbhakdi-Craig V; Sontag JM; Diaz-Arrastia R; Ogris E; Dayal S; Lentz SR; Arning E; Bottiglieri T
    J Neurosci; 2007 Mar; 27(11):2751-9. PubMed ID: 17360897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate deficiency induces in vitro and mouse brain region-specific downregulation of leucine carboxyl methyltransferase-1 and protein phosphatase 2A B(alpha) subunit expression that correlate with enhanced tau phosphorylation.
    Sontag JM; Nunbhakdi-Craig V; Montgomery L; Arning E; Bottiglieri T; Sontag E
    J Neurosci; 2008 Nov; 28(45):11477-87. PubMed ID: 18987184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
    Park HJ; Lee KW; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
    J Neuropathol Exp Neurol; 2018 Feb; 77(2):139-148. PubMed ID: 29281045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
    Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
    Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related alterations in protein phosphatase 2A methylation levels in brains of cynomolgus monkeys: a pilot study.
    Ando S; Sakurai M; Shibutani S; Kimura N; Shimozawa N; Yasutomi Y; Yabe R; Ohama T; Sato K
    J Biochem; 2023 May; 173(6):435-445. PubMed ID: 36702627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucine Carboxyl Methyltransferase 1 (LCMT-1) Methylates Protein Phosphatase 4 (PP4) and Protein Phosphatase 6 (PP6) and Differentially Regulates the Stable Formation of Different PP4 Holoenzymes.
    Hwang J; Lee JA; Pallas DC
    J Biol Chem; 2016 Sep; 291(40):21008-21019. PubMed ID: 27507813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine Carboxyl Methyltransferase Downregulation and Protein Phosphatase Methylesterase Upregulation Contribute Toward the Inhibition of Protein Phosphatase 2A by α-Synuclein.
    Tian H; Lu Y; Liu J; Liu W; Lu L; Duan C; Gao G; Yang H
    Front Aging Neurosci; 2018; 10():173. PubMed ID: 29950985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
    Isono T; Yamashita N; Obara M; Araki T; Nakamura F; Kamiya Y; Alkam T; Nitta A; Nabeshima T; Mikoshiba K; Ohshima T; Goshima Y
    Neurosci Res; 2013 Nov; 77(3):180-5. PubMed ID: 23994236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models.
    Wei H; Zhang HL; Wang XC; Xie JZ; An DD; Wan L; Wang JZ; Zeng Y; Shu XJ; Westermarck J; Lu YM; Ohlmeyer M; Liu R
    Neurotherapeutics; 2020 Jul; 17(3):1087-1103. PubMed ID: 32096091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphyllin I attenuates cognitive impairments and reduces AD-like pathology through CIP2A-PP2A signaling pathway in 3XTg-AD mice.
    Zhou Y; Yang D; Chen H; Zheng C; Jiang H; Liu X; Huang X; Ye S; Song S; Jiang N; Zhao Z; Ma S; Ma J; Huang K; Chen C; Fan X; Gong Y; Wang X; Fan J; Liu R; Shentu Y
    FASEB J; 2020 Dec; 34(12):16414-16431. PubMed ID: 33070372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease.
    Wang X; Hu X; Yang Y; Takata T; Sakurai T
    Exp Neurol; 2015 Sep; 271():145-54. PubMed ID: 26057947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Protein Phosphatase-2A (PP2A) by I1PP2A Leads to Hyperphosphorylation of Tau, Neurodegeneration, and Cognitive Impairment in Rats.
    Wang X; Blanchard J; Tung YC; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2015; 45(2):423-35. PubMed ID: 25589718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.
    Yang CC; Kuai XX; Gao WB; Yu JC; Wang Q; Li L; Zhang L
    J Alzheimers Dis; 2016; 51(1):33-44. PubMed ID: 26836014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine carboxyl methyltransferase 1 (LCMT1)-dependent methylation regulates the association of protein phosphatase 2A and Tau protein with plasma membrane microdomains in neuroblastoma cells.
    Sontag JM; Nunbhakdi-Craig V; Sontag E
    J Biol Chem; 2013 Sep; 288(38):27396-27405. PubMed ID: 23943618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine carboxyl methyltransferase-1 is necessary for normal progression through mitosis in mammalian cells.
    Lee JA; Pallas DC
    J Biol Chem; 2007 Oct; 282(42):30974-84. PubMed ID: 17724024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
    Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
    Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.